Iman Hamour

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Graft microvascular disease in solid organ transplantation

C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation

Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match

Systematic Comparison of Four Cell- and Luminex-Based Methods for Assessment of Complement-Activating HLA Antibodies

Bicaval versus standard technique in orthotopic heart transplant: assessment of atrial performance at magnetic resonance and transthoracic echocardiography

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation

Guideline of transthyretin-related hereditary amyloidosis for clinicians

Wait List Death and Survival Benefit of Kidney Transplantation Among Nonrenal Transplant Recipients

Systemic amyloidosis

Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads

Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

The Amyloid State of Proteins in Human Diseases

Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human disease

A Survey of Current Practice for Antibody-Mediated Rejection in Heart Transplantation

Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy

Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation

Complement‐fixing donor‐specific antibodies identified by a novel C1q assay are associated with allograft loss

Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence

A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation

Chronic Progressive Calcineurin Nephrotoxicity: An Overstated Concept

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Detection of Anti‐HLA Antibodies in Maternal Blood in the Second Trimester to Identify Patients at Risk of Antibody‐Mediated Maternal Anti‐Fetal Rejection and Spontaneous Preterm Delivery

Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate

Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity

Preterm labor: One syndrome, many causes

Heart Transplantation for Homozygous Familial Transthyretin (TTR) V122I Cardiac Amyloidosis

C4d Fixing, Luminex Binding Antibodies—A New Tool for Prediction of Graft Failure After Heart Transplantation

Chronic kidney disease after heart transplantation

De Novo Donor HLA-Specific Antibodies after Heart Transplantation Are an Independent Predictor of Poor Patient Survival

Current outcome of heart transplantation: a 10-year single centre perspective and review